Jaguar Health Inc (JAGX)
3.79
-0.26
(-6.42%)
USD |
NASDAQ |
Jun 17, 16:00
3.82
+0.03
(+0.79%)
After-Hours: 20:00
Jaguar Health Cash from Operations (TTM): -30.34M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -30.34M |
December 31, 2023 | -33.24M |
September 30, 2023 | -32.21M |
June 30, 2023 | -33.95M |
March 31, 2023 | -35.35M |
December 31, 2022 | -33.10M |
September 30, 2022 | -35.60M |
June 30, 2022 | -36.51M |
March 31, 2022 | -35.96M |
December 31, 2021 | -34.97M |
September 30, 2021 | -30.11M |
June 30, 2021 | -23.60M |
March 31, 2021 | -17.69M |
December 31, 2020 | -15.28M |
September 30, 2020 | -14.36M |
June 30, 2020 | -19.98M |
March 31, 2020 | -21.29M |
December 31, 2019 | -20.46M |
September 30, 2019 | -22.22M |
Date | Value |
---|---|
June 30, 2019 | -16.48M |
March 31, 2019 | -16.57M |
December 31, 2018 | -22.73M |
September 30, 2018 | -23.16M |
June 30, 2018 | -23.38M |
March 31, 2018 | -19.16M |
December 31, 2017 | -9.825M |
September 30, 2017 | -7.222M |
June 30, 2017 | -7.577M |
March 31, 2017 | -10.17M |
December 31, 2016 | -14.41M |
September 30, 2016 | -15.62M |
June 30, 2016 | -15.59M |
March 31, 2016 | -17.50M |
December 31, 2015 | -14.32M |
September 30, 2015 | -12.13M |
June 30, 2015 | -10.61M |
March 31, 2015 | -6.085M |
December 31, 2014 | -5.359M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-36.51M
Minimum
Jun 2022
-14.36M
Maximum
Sep 2020
-27.14M
Average
-30.23M
Median
Cash from Operations (TTM) Benchmarks
BioSig Technologies Inc | -12.98M |
Genprex Inc | -23.10M |
Adial Pharmaceuticals Inc | -6.134M |
TFF Pharmaceuticals Inc | -14.82M |
Palisade Bio Inc | -10.79M |